Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $19.33
+12% in 7d after detection
Post-detection moves
1h
—
1d
-3.7%
3d
+5.0%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS